Publicacións en colaboración con investigadores/as de Queen Mary University of London (33)

2024

  1. Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry

    Journal of Cardiac Failure

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  3. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

    Frontiers in Cardiovascular Medicine, Vol. 11

  4. Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction

    Circulation: Genomic and Precision Medicine, Vol. 17, Núm. 2, pp. E004404

  5. Unveiling barocaloric potential in organometallic-sandwich compounds [Cp2M][PF6] (M: Fe3+, Co3+)

    Journal of Materials Chemistry A, Vol. 12, Núm. 35, pp. 23751-23760

2023

  1. Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure

    European Heart Journal, Vol. 44, Núm. 48, pp. 5064-5073

  2. Structure and thermal property relationships in the thermomaterial di-n-butylammonium tetrafluoroborate for multipurpose cooling and cold-storage

    Journal of Materials Chemistry A, Vol. 11, Núm. 41, pp. 22232-22247

2022

  1. Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence

    Cell Death and Disease, Vol. 13, Núm. 2

  2. Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases

    The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 8, pp. e3313-e3320

2021

  1. Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial

    The Lancet Oncology, Vol. 22, Núm. 6, pp. 858-871

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. NF-κB/IKK activation by small extracellular vesicles within the SASP

    Aging Cell, Vol. 20, Núm. 7

  4. Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial

    European Journal of Cancer, Vol. 148, pp. 382-394

2020

  1. Cholecystokinin in the central nervous system of the sea lamprey Petromyzon marinus: precursor identification and neuroanatomical relationships with other neuronal signalling systems

    Brain Structure and Function, Vol. 225, Núm. 1, pp. 249-284

  2. Classical and Nonclassical Intercellular Communication in Senescence and Ageing

    Trends in Cell Biology, Vol. 30, Núm. 8, pp. 628-639

  3. European society of cardiology: Cardiovascular disease statistics 2019

    European Heart Journal, Vol. 41, Núm. 1, pp. 12-85

  4. Extracellular vesicles as potential tools for regenerative therapy

    Molecular and Cellular Oncology, Vol. 7, Núm. 6

  5. Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus

    Circulation: Genomic and Precision Medicine, Vol. 13, Núm. 6, pp. E002769

  6. Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy

    Nature Metabolism, Vol. 2, Núm. 11, pp. 1223-1231

  7. Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage

    Cell Metabolism, Vol. 32, Núm. 1, pp. 71-86.e5